Effect of Topical Application of Hypertonic Saline on Melanoma on Its Sizes and Number.
NCT05854589 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2023-05-11
Summary
This study evaluates the effectiveness of applying Hypertonic Saline solution directly on the Melanomas in reducing their sizes and/or number.
Conditions
- Melanoma (Skin)
Interventions
- DRUG
-
Sodium Chloride Granules
Sodium Chloride crystals
- OTHER
-
Water
Plain distilled water
Sponsors & Collaborators
-
Rafik Batroussy
lead OTHER
Principal Investigators
-
Rafik Batroussy, BPharm · Independent Researcher
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 5 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-08-01
- Primary Completion
- 2024-02-29
- Completion
- 2024-06-30
More Related Trials
-
Antineoplaston Therapy in Treating Patients With Stage IV Melanoma
NCT00003509 ·Status: TERMINATED ·Phase: PHASE2
-
Non-invasive Melanoma Assessment Using a Topical Fluorescence Reagent and Optical Imaging
NCT02056522 ·Status: COMPLETED
-
Study to Compare the Efficacy and Safety of CC-5013 vs. Placebo in Subjects With Metastatic Malignant Melanoma.
NCT00057616 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety and Efficacy of MGD013 in Patients With Melanoma
NCT04653038 ·Status: TERMINATED ·Phase: PHASE1
-
Use of Jet-injection in Photodynamic Therapy for Basal Cell Carcinoma
NCT04552990 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of Obstructive SAS on Metastatic Potential of Cutaneous Melanoma
NCT02699918 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
A Phase II Study of UCN-01 in Metastatic Melanoma
NCT00072189 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Efficacy of an Immune Response Modifier to Treat Inoperable Advanced Melanoma Skin Lesions
NCT00091689 ·Status: COMPLETED ·Phase: PHASE1
-
Intratumoral Injection Of Alpha-Gal Glycosphingolipids
NCT00668512 ·Status: COMPLETED ·Phase: PHASE1
-
Pulsed Dye Laser in Treating Superficial Basal Cell Carcinomas
NCT02125669 ·Status: COMPLETED ·Phase: NA
-
One-stop-shop Study for Treatment of Basal Cell Carcinoma Using Reflectance Confocal Microscopy
NCT02285790 ·Status: COMPLETED ·Phase: NA
-
A Study To Assess The Safety Of Administering CP-675,206 As A One Hour Infusion In Patients With Surgically Incurable Advanced Melanoma
NCT00585000 ·Status: TERMINATED ·Phase: PHASE1
-
Efficacy Study Of P276-00 In Subjects Of Malignant Melanoma Positive For Cyclin D1 Expression
NCT00835419 ·Status: COMPLETED ·Phase: PHASE2
-
Open-Label Study of TPI 287 for Patients With Metastatic Melanoma
NCT01340729 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Treatment Use Study for Advanced Melanoma.
NCT00584493 ·Status: NO_LONGER_AVAILABLE
-
Masitinib in Non-Resectable or Metastatic Stage 3/4 Melanoma Carrying a Mutation in the Juxta Membrane Domain of c-Kit
NCT01280565 ·Status: TERMINATED ·Phase: PHASE3
-
CBL0137 in Treating Patients With Advanced Extremity Melanoma or Sarcoma
NCT03727789 ·Status: TERMINATED ·Phase: PHASE1
-
A Study Comparing GSK2118436 to Dacarbazine (DTIC) in Previously Untreated Subjects With BRAF Mutation Positive Advanced (Stage III) or Metastatic (Stage IV) Melanoma
NCT01227889 ·Status: COMPLETED ·Phase: PHASE3
-
GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive Melanoma
NCT01245062 ·Status: COMPLETED ·Phase: PHASE3
-
Role of SLURP-1 in Melanoma and Melanoma Stem Cells
NCT01281722 ·Status: UNKNOWN
-
A Comparison of Skin Grafts Versus Local Flaps for Facial Skin Cancer From the Patient Perspective: A Feasibility Study
NCT04805905 ·Status: UNKNOWN
-
Disulfiram and Chelated Zinc for the Rx of Disseminated Mets Mel That Has Failed First Line Therapy
NCT02101008 ·Status: COMPLETED ·Phase: PHASE2
-
Laser Immunotherapy With and Without Topical Anti-PD1 in Basal Cell Carcinomas
NCT04570683 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Intralesional Sclerosant for in Transit and Cutaneous Melanoma Metastases
NCT03754140 ·Status: WITHDRAWN ·Phase: PHASE2
-
CCI-779 in Treating Patients With Metastatic Melanoma
NCT00022464 ·Status: COMPLETED ·Phase: PHASE2